Literature DB >> 4982036

Inhibition of S-91 mouse melanoma metastases and growth by D-penicillamine.

B T Hourani, H B Demopoulos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4982036

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


× No keyword cloud information.
  5 in total

1.  Tumour-cell-endothelial interactions: free radicals are mediators of melanoma-induced endothelial cell damage.

Authors:  F A Offner; J Schiefer; H C Wirtz; I Bigalke; M Pavelka; G Hollweg; C Ensinger; B Klosterhalfen; C Mittermayer; C J Kirkpatrick
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

2.  Somatic cell hybrids producing inhibitors of melanotic melanoma tyrosine hydroxylase.

Authors:  A A Hakim
Journal:  Experientia       Date:  1982-02-15

3.  Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.

Authors:  Steven Brem; Stuart A Grossman; Kathryn A Carson; Pamela New; Surasak Phuphanich; Jane B Alavi; Tom Mikkelsen; Joy D Fisher
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

4.  Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.

Authors:  S S Brem; D Zagzag; A M Tsanaclis; S Gately; M P Elkouby; S E Brien
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

5.  Suppression of 9L gliosarcoma growth by copper depletion with copper-deficient diet and D-penicillamine.

Authors:  D Yoshida; Y Ikeda; S Nakazawa
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.